Xylazine: What the HIV Care Team Needs to Know

Presented by Raagini Jawa, MD, MPH, FASAM, and Justin Alves, RN, FNP-BC, AACRN, ACRN, CARN, CNE, this training will review the growing effect of xylazine contamination of the drug supply for people who use drugs. Epidemiological and geographic trends in xylazine exposure and consumption will be reviewed. Signs, symptoms, and effects of xylazine exposure will be reviewed and provide helpful insights for HIV care teams on how to identify people who are affected by xylazine and how to adjust services to meet the needs of people using drugs and living with HIV. Register for the session here. This session will not be recorded.